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INTRODUCTION
Myotonic dystrophy type 1 (DM1) is caused by a CTG trinu-
cleotide repeat expansion in the 3’untranslated region of the 
dystrophia myotonica-protein kinase (DMPK) gene on chro-
mosome 19q13.1 A disease of the muscles, DM1 leads to pro-
gressive weakness and wasting, especially in the distal muscle. 
Patients with DM1 also show abnormalities in a variety of other 
systems, including the heart and brain, presenting symptoms 
of cardiac conduction defects, cognitive impairment, personal-
ity changes, and hypersomnia.1 
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Results: Cortical thickness was significantly reduced in the frontal, temporal, and occipital cortices, while tract-based spatial sta-
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Cognitive deficits have been observed in 24–75% of DM1 pa-
tients,2-4 including reduced visuospatial/constructional abili-
ties, attention, verbal memory, and even severe cognitive de-
cline. Several neuropsychological studies have shown reduced 
intelligence quotient (IQ) scores and concurrent deficits in ex-
ecutive function and visuospatial construction ability.3,5 In as-
sociation with the cognitive deficits observed in DM1, structur-
al and functional abnormalities of the brain have been reported, 
which include white matter lesions and atrophy,6 decreased 
cerebral glucose metabolism,7 hypoperfusion in the fronto-tem-
poro-parietal cortex,5 and reduced cerebral blood flow.3,5 Vox-
el based morphometry has revealed gray matter atrophy in 
the bilateral frontal, parietal lobes, and in the temporo-occipi-
tal gyrus, while diffusion tensor imaging (DTI) has highlighted 
regional white matter atrophy in the corpus callosum.8,9 
Although it has been widely accepted that the size of CTG ex-
pansion is closely related to clinical severity of DM1,10,11 the 
relationship between CTG repeats size and structural changes 
in the brain has yet to be proven. Only limited evidence has dem-
onstrated a correlation of CTG repeat size with neuropsycho-
logical tests,12,13 and there are some contradictory results.14 As 
the brain is composed of highly specialized functioning areas, 
area information in relation to CTG repeats size would hold im-
portant clinical implications. 
The aim of the present study was to delineate global changes 
in cortical thickness and white matter integrity in patients with 
DM1, compared to age-matched healthy controls, using struc-
tural magnetic resonance imaging (MRI) and DTI. Further-
more, areas that were highly correlated with CTG repeat size 
were explored both in the cortical and white matter areas, as well 
as its relevance to IQ scores.
MATERIALS AND METHODS
Participants 
Nine patients with adult DM1 who were treated at Gangnam 
Severance Hospital agreed to participate in this study. The in-
clusion criteria were 1) age between 20 and 60 years and 2) ge-
netic confirmation of DM1, which was established by poly-
merase chain reaction (PCR) and Southern blot analysis. 
Abnormal nucleotide repeats in the 3’-untranslated end of the 
DMPK gene amplification were detected by PCR-Southern blot 
analysis from serum DNA. DM1 was diagnosed based on the 
presence of 50 or more CTG repeats. 
Patients with DM1 were age and education level-matched 
with nine healthy control participants. The MRI data from the 
patient group were compared with those from the control group.
This study was approved by the Institutional Review Boards 
of Gangnam Severance Hospital and the Hallym University 
Sacred Heart Hospital. Written informed consent was obtained 
from all of the participants. 
Methods
MRI acquisition 
We acquired MR images using a 3T Philips Intera Scanner (Phil-
ips Intera, Amsterdam, the Netherland) located at Hallym Uni-
versity Sacred Heart Hospital, which was equipped with an 
eight-channel head coil. High-resolution T1-weighted imaging 
was acquired using multi shot turbo field echo pulse sequence 
[repetition time (TR)=9.3 ms; echo time (TE)=4.6 ms; flip angle= 
8o; field of view (FOV)=230×230 mm, slice thickness=1 mm, 
160 slices]. DTI was conducted using a diffusion-weighted-
echo planar imaging sequence (TR=10427 ms; TE=60 ms; slice 
thickness=2.25 mm; no gap; FOV=230×230 mm). A total of 60 
slices were obtained with 45 independent diffusion gradient di-
rections using b=1000 s/mm2 and one image with b=0 s/mm2. 
Cortical thickness analysis using 3D T1 volume
T1-weighted 3D volume images were analyzed with FreeSurf-
er software (v5.0, Athinoula A. Martinos Center for Biomedical 
Imaging, Charlestown, MA, USA). FreeSurfer is a semi-automat-
ed brain morphometry tool, and details on this post-process-
ing sequence have been described elsewhere.15 Briefly, a sin-
gle MPRAGE image was automatically normalized for intensity 
inhomogeneity to obtain a high contrast-to-noise volume. Iden-
tification of the gray/white matter boundary (white matter sur-
face) and, in turn, the gray/CSF boundary (gray matter surface)15 
was automatically processed using the intensity-normalized 
volume. Cortical thickness measurements were then obtained 
by calculating the distance between these two boundaries 
across the entire cortical mantle of each hemisphere.
Diffusion tensor image analysis
First, we performed voxel-wise analyses of fractional anisotro-
py (FA) maps across subjects using tract-based spatial statistics 
(TBSS) on data from patients with DM1 and controls. In this pro-
cess, eddy currents correction, non-brain tissue removal, DTI 
data calculation, skeletonization to generate a white matter tract 
skeleton,16 and statistical analysis between groups were all con-
ducted. Then, FA values were extracted from the region of in-
terests (ROIs) (orbitofrontal left, optic radiation both, external 
capsule both, postcentral left, insular both) using the fslmeants 
commands. Lastly, the mean FA values of each ROI were corre-
lated with the number of CTG repeats.
Intelligence quotient testing
The Korean version of the Wechsler Adult Intelligence Scale 
(K-WAIS) was used to evaluate the patients’ cognitive function-
ing. IQ tests were administered within 1 or 2 days difference of 
the MR acquisition. The Wechsler Adult Intelligence Scale is 
an individually administered, neuropsychological test for the 
measurement of intellectual capacity using IQ to quantify ca-
pacity. The test consists of subtests for verbal IQ, performance 
IQ, and full scale IQ. The full-scale IQ score is derived from the 
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combination of the verbal and performance scores. On the K-
WAIS, IQ scores ranging from 90–109 are ‘average’, and IQ scores 
ranging from 80–89 are ‘below average’.
Statistics
A general linear model was used to analyze cortical thickness 
values, which were estimated at each vertex across the cortical 
surface for comparison between patients with DM1 and controls, 
Fig. 1. MRI images of cortical thickness (A) and white matter integrity (B) maps based on age-adjusted means of patients compared to those of 
healthy control subjects (n=9). (A) The map shows the distribution of p-values for pairwise comparisons between patients and healthy controls 
(p=0.01 to p=0.00001). Blue color represents decreased cortical thickness in patients with myotonia compared to controls (p<0.01 corrected for multi-
ple comparisons; Monte Carlo simulation: 10000 iterations). The color-coding for p-values is on a logarithmic scale of 1–5. Cooler colors (negative val-
ues) represent cortical thinning. (B) TBSS shows decreased areas of white matter integrity in patients compared to controls (p<0.002; cluster-wise 
corrected). Blue color represents areas of decreased FA in patients compared to controls (right 1st row), whereas pink colored areas represent ar-
eas of increased AD (right 2nd row), and green colored area showed areas of increased RD (right 3rd row). TBSS, tract-based spatial statistics; FA, frac-
tional anisotropy; AD, axial diffusivity; RD, radial diffusivity.
A B
Fig. 2. Areas of correlation of cortical thickness (A) and FA value with number of CTG repeats (B). (A) Blue color represents areas where cortical 
thickness negatively correlated with the number of CTG repeats (p<0.01, uncorrected). (B) Red-orange color represents areas where FA value nega-
tively correlated with the number of CTG repeats (p<0.003, uncorrected). FA, fractional anisotropy.
A B
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with cortical thickness as the dependent variable. Age was includ-
ed as a nuisance variable. The left and right cortical surfaces of 
each hemisphere were analyzed separately. Clusters of vertices 
exceeding p<0.01 with differences in thickness according to 
grouping, with age as a nuisance variable, were identified, and 
cluster-wise statistical significances were calculated via 10000 
instances of a Monte Carlo simulation (p=0.01) (Fig. 1A). The re-
lationship between the mutation effect and cortical thickness 
was investigated by including the number of CTG repeats into 
the general linear model as covariates as described above and 
using uncorrected p<0.001 as a reduced threshold for signifi-
cance (visualized with uncorrected p<0.01) (Fig. 1B).
For DTI analysis, each DTI metric [FA, axial diffusivity (AD), 
and radial diffusivity (RD)] was projected onto the skeletons 
in cluster-wise statistical comparisons. Independent t-tests were 
conducted using permutation-based non-parametric testing 
and incorporating age as a nuisance variable. We formed clus-
ters at t>4 and tested for significance at p<0.05, corrected for 
multiple comparisons across space (Fig. 1B). The relationship 
between the mutation effect and FA values was investigated 
by including the number of CTG repeats into the model as co-
variates using uncorrected p<0.005 as a threshold for signifi-
cance (Fig. 2B). Spearman correlations between the number 
of CTG repeats and either cortical thickness or FA value were 
considered significant at p<0.05. 
The Wilcoxon signed-rank test was used for cognition sub-
scale analysis to evaluate differences between verbal and per-
formance IQ scores of patients with DM1. Additionally, we used 
Spearman’s correlation analyses to detect relationships between 
IQ scores and the number of CTG repetitions.
RESULTS
Comparison between DM1 and controls
Demographic characteristics
In the control group, six men and three women were included 
with ages ranging from 27 to 55 years [47 (27, 55) median (inter-
quartile range (IQR)]. The group of patients included five men 
and four women with ages ranging from 27 to 52 years [42 (36, 
48) median (IQR)]. The average duration of disease was 5.2±1.4 
years. The patients had a median of 300 (150, 400) CTG elonga-
tions (ranging from 120 to 400) (Table 1). The baseline demo-
graphic characteristics showed no significant difference be-
tween groups (p>0.05).
Table 2. Reduction of Vertex Cortical Thickness Compared to Controls
Cortex Tal X Tal Y Tal Z Area (mm2)* CWP
Left hemisphere
Transverse temporal -54.4 -16.8 3.4 3791.5 0.0001
Precuneus -4.3 -64.7 33.8 3001.5 0.0001
Lateral occipital -28.1 -83.6 3.6 2100.5 0.0001
Superior frontal -13.9 39.9 40.0 963.6 0.0005
Postcentral -17.5 -35.5 66.7 910.4 0.0008
Precentral -56.6 5.1 13.1 792.3 0.0025
Precentral -42.6 -5.1 48.5 660.0 0.0087
Right hemisphere
Supramarginal 51.7 -34.7 43.2 3467.3 0.0017
Superior parietal 29.9 -61.6 26.4 2684.4 0.0001
Lateral occipital 45.9 -65.1 -6.2 1257.1 0.0001
Superior frontal 8.7 54.9 26.2 1073.2 0.0001
Precuneus 19.8 -58.0 27.9 839.8 0.0007
Superior temporal 55.1 4.8 -8.1 707.9 0.0032
Paracentral 2.9 -31.2 65.4 571.7 0.0149
Entorhinal 22.3 -16.8 -23.0 459.6 0.0458
CWP, cluster-wise p-value; Tal, Talairach coordinate.
Cluster-wise statistics were determined by a Monte Carlo simulation.
*Surface area of cluster in standardized cortical surface. 
Table 1. Demographic Characteristics
Controls Myotonia
Gender (male:female) 6:3 5:4
Age (yr) Median 47 (27, 55) Median 42 (36, 48)
Duration of disease (yr) Median 5 (5, 6) -
CTG repeats (n) Median 300 (150, 400) -
Education level (n)
Secondary school 1 0
High school dropout 1 0
High school 4 6
Associate degree 2 0
University 1 3
Parentheses indicate interquartile range.
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Cortical changes
Cortical thickness was significantly reduced in the clusters of 
the bilateral superior temporal cortices (including the supra-
marginal cortex), precuneus, lateral occipital cortex, superior 
frontal, precentral, and postcentral cortices in the patient group, 
compared to controls. The thickness of the entorhinal cortex was 
only decreased in the right hemisphere (Fig. 1A).
White matter changes
Voxel-based mapping using TBSS showed decreased FA values 
in widespread areas, including bilateral orbitofrontal cortices, 
anterior frontal fibers (includes genu portion corpus callosum), 
the insular cortex, the external capsule, and the occipital cortex 
(includes optic radiation) in patients, compared to control sub-
jects. Increased RD, which is suggested to be related with a my-
elinopathy condition, was noted in the patient group, compared 
to the control subjects, in similar but more widely distributed 
areas. However, analyses of the AD values demonstrated that 
only the genu of the corpus callosum and both anterior and pos-
terior corona radiata were increased in the patient group, com-
pared to the control group (Fig. 1B).
Correlation with CTG repeats
Cortical thickness of the middle temporal, supramarginal, 
and lateral occipital cortices in the left hemisphere and in the 
medial orbitofrontal and inferior parietal cortices in the right 
hemisphere were negatively correlated with the number of 
CTG repeats (p<0.001, uncorrected) (Figs. 2A and 3A, Table 2), 
while white matter integrity measured by FA values in the orbi-
tofrontal and entorhinal areas, as well as the anterior corona 
radiata and lateral occipital white matter, in the left hemi-
sphere and the precuneus white matter in the right hemi-
sphere were negatively correlated with the number of CTG re-
peats (p<0.003, uncorrected) (Figs. 2B and 3B, Table 3).
Intelligence quotient scores
All patients completed the K-WAIS. Only one patient had a be-
low average full scale IQ at 84. The others had IQ scores in the 
average (IQ 90–109) or above ranges. The performance IQ was 
lower than verbal IQ; in particular, picture completion, block 
design, and object assembly were relatively lower in the sub-
test of performance IQ. There were no differences between ver-
bal and performance IQ scores (p=0.11). In addition, no statis-
Table 3. Changes in Diffusion Parameters Compared to Controls
White matter MNI X MNI Y MNI Z (mm) Voxels Z-max*
FA (decreased) 
Lt. Orbitofrontal -23 15 -21 5243 0.002
Rt. Optic radiation 37 -51 -3 2541 0.002
Lt. Optic radiation -33 -66 -2 2030 0.002
Rt. External capsule 41 -9 -19 738 0.002
Lt. Postcentral -54 -5 16 395 0.002
Rt. Insular 33 4 -13 304 0.002
Lt. Insular -34 -14 -7 207 0.002
Lt. External capsule -21 19 -10 207 0.002
AD (increased)
Splenium of CC -11 -42 16 246 0.002
Rt. Precuneus 30 -50 15 192 0.002
Genu of CC 14 32 -3 190 0.002
Lt. External capsule -26 16 8 157 0.002
Lt. Anterior corona radiata -26 27 19 113 0.002
Lt. Inferior temporal -41 -7 -29 93 0.002
RD (increased)
Genu of CC -14 31 -22 11295 0.002
Bilateral Optic radiation -32 -68 -2 5461 0.002
Rt. Temporal fusiform 33 -7 -38 1181 0.002
Lt. Temporal fusiform -36 -9 -38 1168 0.002
Lt. Secondary somatosensory -49 -14 26 692 0.002
Lt. External capsule -31 -3 10 498 0.002
Lt. Sagittal stratum -43 -29 -9 482 0.002
Lt. Orbitofrontal -20 19 -13 282 0.002
Lt. Fusiform 40 -50 -16 273 0.002
Rt. Optic radiation 26 -80 1 150 0.002
FA, fractional anisotropy; CC, corpus callosum; AD, axial diffusivity; RD, radial diffusivity; MNI, Montreal Neurological Institute brain.
Cluster-wise statistics was determined by permutation test.
*Cluster-wise p-value.
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tically significant correlation was found between IQ scores and 
the size of CTG repeats. 
DISCUSSION
In the present study, analyses of patients with DM1 demon-
strated changes in gray and white matter in the widely distrib-
uted network of the frontal, temporo-occipital, medial parietal, 
and sensorimotor areas. These differences between patients 
and control subjects were similar in distribution but more ex-
tensive in white matter. In relation to CTG expansion size, sig-
nificant negative correlation were found with the cortical thick-
ness in the right medial orbitofrontal cortex, left middle temporal, 
supramarginal, and the lateral occipital cortex, along with FA in 
the orbitofrontal, left entorhinal, anterior coronal, and lateral 
occipital cortices.
Research on brain involvement in adult-onset DM1 has in-
creased in recent years, revealing cognitive dysfunction, as 
well as underlying brain anomalies.17 Previous neuroimaging 
studies have demonstrated predominant white matter abnor-
malities rather than cortical changes in the brain. Symmetrical 
subcortical white matter lesions with a breakdown of myelin 
sheaths and relative preservation of axons in patients with DM1 
are the most common previously reported pathological mark-
er.18,19 Group comparison between patients and control sub-
jects in this study revealed higher occurrence of white matter 
abnormalities than cortical abnormalities, which was in line 
with previous reports.18,20 Detailed analyses of white matter 
microstructure using DTI showed that white matter lesions 
mostly represent myelinopathy, as areas of change in mean dif-
fusivity values were mostly influenced by RD values, except 
corpus callosal changes in AD. This finding together with the 
correlation between white matter lesion severity and disease 
duration suggests that DM1 represents a slow demyelinating 
process.18,20 The demyelination eventually progresses to axo-
nopathy, leading to ventricular dilatation, which is significantly 
more common in patients with severely disturbed intellect.2 
Previously reported data also suggest changes in the widely dis-
tributed white matter involving most of the cerebrum and cor-
tical fibers.9,17,21 
Considering documented impairment on tests of frontal lobe 
function, such as attention demanding-dual tasks and frontal 
executive functions in DM1,3,5 white matter pathology observed 
in our study may suggest that this type of deficit does not cor-
relate with cortical atrophy but specifically with white matter 
lesions in the frontal lobes, including orbitofrontal, inferior 
frontal, and prefrontal white matter. As demonstrated by our 
results, decreased integrity of connectivity, as well as cortical 
pathology, was located mostly in the ventral side connecting 
the fronto-temporal cortex. These findings may be relevant to 
the behavioral symptoms related to fronto-temporal cortex, 


























































































































Woo-Kyoung Yoo, et al.
https://doi.org/10.3349/ymj.2017.58.4.807
including dysexecutive syndrome, apathy, depression, anxi-
ety, obsessive-compulsive, avoidant, and passive-aggressive 
behavior, which was observed in DM1.6 In the present study, we 
also found changes in diffusion metrics in the external capsule, 
which might be related to decreased verbal fluency resulting 
from impairment in semantic processing.22 
We also observed pronounced changes in cortical thickness 
and white matter integrity, mainly in the temporo-occipital and 
parietal areas in the medial side, including the precuneus. Cor-
tical changes in patients with DM1 have been well document-
ed using MRI, including regional neuronal loss in the parietal 
region, extending to the anterior and superior middle tempo-
ral and occipital lobes.5,8,23,24 It is interesting to note that the pre-
cuneus, in combination with the anterior cingulate, is an im-
portant node of the default mode network. The present results 
revealed decreased cortical thickness and white matter integ-
rity, which may underlie decreased alertness and autobiograph-
ical memory.25-27
The overall IQ scores, as measured by the K-WAIS, were with-
in the normal range in the present study, in contrast with low-
er-than-age and education-matched controls reported in earli-
er studies.7,12,28 Patients with DM1 with IQ scores similar to those 
of the normal population reportedly have impairments in vi-
sual functions, including visual perception, constructional abil-
ity, and visual memory.5,29 The performance IQ was lower than 
the verbal IQ in all the cases in the present study, but this was 
not statistically significant. We believe that this finding is relat-
ed to both cortical and white matter abnormalities in occipital 
lobes. In addition, given that the visuospatial attention network 
is closely linked to increases in signal-to-noise ratio in the visual 
pathway, attention deficits in patients with DM1 described in 
previous studies might be explained by the present findings of 
occipital changes.4,30
Considering documented evidence of impairment in tests 
of frontal lobe function in patients with myotonic dystrophy,3,5 
the white matter pathology observed in this study may sug-
gest that this type of deficit does not correlate with cortical at-
rophy but instead with white matter lesions in the frontal lobe, 
including the orbitofrontal, inferior frontal and prefrontal re-
gions. A recently published study showed greater MD increas-
es and FA decreases are related to more cortical thinning in 
healthy subjects, in areas with partial overlapping with but 
outside the projected tract endings.31 Our results were different 
as the white matter integrity was far more changed than that 
of the cortical thickness in our patient group; this would not be 
mere changes in cortical thickness outside the tract projection. 
DM1 is a trinucleotide repeat disorder of the non-coding re-
gion, and there is some evidence that the severity of DM1 cor-
relates with the number of CTG repeats.1,32 Previous results 
showed that the number of CTG expansions correlates with 
disease severity, inversely to age of onset, and diffuse subcor-
tical involvement,33-35 especially in the frontal lobes.12,36 Although 
the results of those studies demonstrated correlations between 
cortical changes in diverse brain areas and increased CTG re-
peats, it is interesting to note that frontal areas and brain areas 
involved in memory showed significant differences between 
the patient and control groups. Transgene DMPK RNA levels 
in the frontal cortex were found to be approximately three times 
higher than those of endogenous murine DMPK RNA in ho-
mozygous mice carrying over 1000 CTG.37 These findings are 
consistent with a higher relative expression of the transgene 
in this brain region co-occurring with longer CTG repeats and 
may support findings of a correlation between number of CTG 
repeats in the medial frontal and prefrontal white matter ar-
eas.37 The findings may also be related to the dysexecutive syn-
drome observed in patients with DM1.3,5 Our TBSS results in-
dicating differences in the hippocampus and parahippocampal 
gyrus may be clinically significant because these areas are 
known to contribute significantly to learning and memory pro-
cesses.38 These structures are also connected with the precune-
us, which has been established as an important node for the 
default mode network that is related to the mental processes 
presumed to be ongoing in a resting state.39 In addition, the 
precuneus is connected to the orbitofrontal cortex and the me-
dial prefrontal cortex, which have been implicated in the inte-
gration of cognitive and emotional stimuli,40,41 and therefore, 
may suggest functional implications in related symptoms. 
However, very little is known about the relationship between 
brain abnormalities and cognitive dysfunction in patients with 
DM1. Therefore, further studies are needed to understand brain 
involvement in the disease duration and range of cognitive 
function.
There are several limitations to this study: first, this study in-
cluded a small number of participants; therefore, observations 
here may not be generalizable to all patients with DM1. Second-
ly, IQ test was performed only in the patient group, which made 
it difficult to interpret related IQ group differences. However, 
if one considers the fact that this study focused mainly on the 
relationship with CTG repeats, as well as the IQ results, which 
showed average score, it might be plausible to interpret the re-
sults as above. Another limitation of this study is the correlation 
analysis finding is based on the IQ tests not based on whole 
neuropsychological tests, which is warranted a future study 
about the relationship the CTG repeats how it correlated with 
neuroimaging metrics. 
In conclusion, our results suggest that DM1 patients show 1) 
changes in gray and white matter in widely distributions of simi-
lar networks, although more extensively in white matter char-
acterized by myelinopathy, 2) gray and white matter integrity 
that is correlated with CTG repeats, and 3) that the anatomical 
location correlated with CTG repeats expansion size is well re-
lated with the characteristic cognitive deficits of these patients, 
although these lesions show no correlation with IQ tests. 
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